Spironolactone does help reduce facial hair in women, and it is one of the most commonly prescribed medications for this purpose. Originally developed as a blood-pressure drug, spironolactone turned out to have strong anti-androgen effects that slow the growth of hormone-driven hair on the face, chest, and abdomen. It is not FDA-approved specifically for hirsutism, but decades of clinical use and trial data have made it a first-line off-label treatment in dermatology and endocrinology.
Why Facial Hair Grows in the First Place
Facial hair in women is driven by androgens, the group of hormones that includes testosterone and its more potent derivative, dihydrotestosterone (DHT). Under the influence of androgens, fine, nearly invisible hairs on the face can be stimulated to become thicker, darker, and coarser. The degree to which this happens depends in part on the activity of an enzyme called 5-alpha reductase, which converts testosterone into DHT at the hair follicle itself.1Endocrine Reviews. Idiopathic Hirsutism This means that even women with normal overall androgen levels can develop unwanted facial hair if their follicles are especially sensitive to these hormones or produce more DHT locally. The two most common diagnoses behind excessive facial hair are polycystic ovary syndrome (PCOS), which raises circulating androgen levels, and idiopathic hirsutism, where androgen levels look normal on bloodwork but the follicles still over-respond.
How Spironolactone Works Against Facial Hair
Spironolactone attacks the androgen-driven hair growth cycle from several angles. It competes directly with testosterone and DHT for the androgen receptor, essentially blocking those hormones from reaching the hair follicle. It also reduces 5-alpha reductase activity, which lowers the amount of DHT produced at the skin. On top of that, spironolactone raises levels of sex hormone-binding globulin, a protein that binds testosterone in the blood and makes it less available to tissues. It even suppresses testosterone production itself by interfering with enzymes involved in making the hormone.2Journal of Biosciences and Medicines. Androgens/Androgen Receptor in the Management of Skin Diseases The combined effect is a meaningful reduction in androgen activity at the follicle, which over time causes hairs to become finer and grow more slowly.
It is worth understanding that spironolactone does not remove existing hairs. It changes the growth cycle so that new hairs come in thinner and lighter, and the interval between growth cycles lengthens. This is why results take months to become noticeable and why many women combine the medication with physical hair removal methods like laser or electrolysis while waiting for the drug to take full effect.
How Well It Actually Works
Clinical trials consistently show that spironolactone produces a meaningful reduction in hirsutism, typically measured by the Ferriman-Gallwey score, a standardized scale that grades hair growth in nine body areas. In a randomized, double-blind, placebo-controlled trial comparing spironolactone to flutamide and finasteride, women taking spironolactone saw their scores drop by about 41% after six months of treatment.3PubMed. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial A study in women with PCOS found that scores dropped from roughly 12 down to about 7 in lean women and from about 10 down to 5 in overweight women, both statistically significant improvements.4PubMed Central. Efficacy of Spironolactone in Adult Acne in Polycystic Ovary Syndrome Patients an Original Research
These numbers translate to real-world changes that women can see and feel. A score drop from 12 to 7 often means the difference between needing to manage visible facial hair daily and being able to go a few days between grooming. That said, spironolactone rarely eliminates facial hair entirely. Most women experience a noticeable improvement rather than a complete resolution, which is part of why combining medical treatment with hair removal procedures remains standard practice.
Does the Underlying Cause Matter?
One of the reassuring findings in the research is that spironolactone works whether the excess hair is caused by PCOS or by idiopathic hirsutism, where no clear hormonal abnormality can be identified. Early studies established this, and it has been confirmed repeatedly since.5JAMA. Treatment of Hirsutism With Spironolactone 6PubMed Central. Spironolactone in the treatment of idiopathic hirsutism and the polycystic ovary syndrome This makes clinical sense, because regardless of whether excess androgens are circulating in the blood or the follicle is just overly sensitive, the drug’s receptor-blocking action at the skin level addresses both scenarios.
That said, PCOS patients sometimes benefit from additional treatment. In one long-term comparison, spironolactone reduced hirsutism in women with PCOS but was less effective than cyproterone acetate at bringing scores down to the same degree after 12 months. The authors noted that for the hormonal and metabolic issues associated with PCOS, spironolactone alone may not be enough, and combining it with an insulin-sensitizing drug or an oral contraceptive could improve outcomes.7PubMed. Spironolactone as a single agent for long-term therapy of hirsute patients Women with idiopathic hirsutism, by contrast, tend to do well on spironolactone alone.
What Dose Is Used and Does It Matter?
The typical dose for hirsutism is 100 to 200 mg per day, usually split into two doses. Dermatologists often start on the lower end and increase if needed. A Cochrane review examined one small trial that compared 100 mg against 200 mg and found that hair shaft diameter decreased in both groups, by about 19% and 30% respectively. Although the higher dose appeared to produce a larger reduction, the difference between the two doses did not reach statistical significance in the review’s analysis.8Cochrane Database of Systematic Reviews. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne
Other evidence suggests the picture is more nuanced. A review of hirsutism management noted that the effectiveness of spironolactone is dose-dependent: lower doses are less active than other anti-androgens, while higher doses around 200 mg per day are very effective but come with more side effects, particularly irregular menstrual bleeding.9PubMed. Management of hirsutism In practice, many clinicians find that 100 mg per day offers a reasonable balance between efficacy and tolerability, especially when combined with an oral contraceptive that can offset the menstrual side effects.
Combining Spironolactone With Oral Contraceptives
Pairing spironolactone with a combined oral contraceptive pill is common practice and addresses multiple problems at once. The contraceptive provides reliable birth control, which matters because spironolactone can cause serious harm to a developing male fetus. The estrogen component also suppresses ovarian androgen production and raises sex hormone-binding globulin, giving an additive anti-androgen effect. And it helps manage the irregular bleeding that spironolactone can cause on its own.10PubMed. Use of spironolactone in treatment of hirsutism
A randomized trial compared three combination regimens and found that all three reduced hirsutism scores by roughly 45 to 49% at six months. There was no significant difference between the groups, suggesting that the specific type of oral contraceptive paired with spironolactone matters less than the fact that they are combined.11PubMed. Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens For women who cannot or prefer not to take hormonal contraception, other forms of birth control are still recommended while on spironolactone, given the pregnancy risk.
How Spironolactone Compares to Other Anti-Androgens
Several anti-androgen drugs are used for hirsutism worldwide, including cyproterone acetate and finasteride. In the placebo-controlled trial mentioned earlier, spironolactone, flutamide, and finasteride all produced similar reductions in hirsutism scores and hair diameter after six months, with no statistically significant differences between them.3PubMed. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial Where spironolactone stands out is in what happens after treatment stops. In a head-to-head trial with cyproterone acetate and finasteride, all three drugs reduced hirsutism scores by a similar percentage during treatment, but one year after stopping, women who had used spironolactone maintained a significantly lower score than those who had taken the other two drugs.12PubMed. Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism
Cyproterone acetate is not available in the United States, which makes spironolactone the default first-choice anti-androgen for American women. Flutamide carries a risk of serious liver toxicity that limits its use. In practice, spironolactone’s long safety track record, low cost, and decent efficacy make it the go-to option in most English-speaking countries.
What Happens When You Stop Taking It
One of the more practical questions people have is whether facial hair comes roaring back the moment they stop the medication. The evidence here is mixed but more encouraging than many expect. A study that followed women after discontinuation found that about two-thirds of patients still had prolonged benefit roughly 34 months after stopping spironolactone, while one-third relapsed at an average of about 18 months after discontinuation.13PubMed. Long-Lasting Effects of Spironolactone after its Withdrawal in Patients with Hyperandrogenic Skin Disorders Women with more typical, classic PCOS were treated longer and relapsed later than those with ovulatory PCOS, suggesting that the duration of treatment matters.
This does not mean spironolactone permanently changes the follicle. The androgens that drive hair growth are still present once the drug is gone. But the sustained effects may reflect a period during which follicles have been shifted back toward a finer growth pattern and take time to revert. For many women, the practical strategy is to stay on spironolactone for a prolonged course, potentially years, and to use that window to pursue permanent hair reduction through laser or electrolysis.
Safety Concerns and the Pregnancy Question
Spironolactone’s most serious risk is to pregnancy. Because the drug blocks androgen receptors, exposure during pregnancy can interfere with the normal development of a male fetus, potentially feminizing the genitalia.14PubMed Central. Case report: A pregnant woman accidental treated with spironolactone in mid-gestation This is why reliable contraception is considered non-negotiable while taking the drug, and why prescribers typically confirm a negative pregnancy test before starting it.
Beyond pregnancy, the most common side effects are related to spironolactone’s original purpose as a diuretic and potassium-sparing drug. These include increased urination, dizziness from lowered blood pressure, breast tenderness, and irregular periods. The menstrual irregularity is the side effect that drives the most complaints, which is another reason combining it with an oral contraceptive is popular. Elevated potassium levels are a theoretical risk, and periodic blood testing is sometimes recommended, though in otherwise healthy young women the risk is low. Spironolactone has been used at these doses for decades, and serious adverse events in the hirsutism population remain rare.
Getting the Right Workup Before Starting
Before a prescriber reaches for spironolactone, the Endocrine Society recommends evaluating the cause of hirsutism, particularly in women with moderate-to-severe hair growth and elevated testosterone. While PCOS is the most common culprit, clinicians need to exclude other conditions that can look similar, including adrenal and ovarian tumors, congenital adrenal hyperplasia, and other endocrine disorders.15The Journal of Clinical Endocrinology & Metabolism. Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline This evaluation usually involves bloodwork for androgens, sometimes imaging, and a careful history. Jumping straight to spironolactone without this step risks masking a more serious condition.
Facial Hair Reduction in Transgender Women
Spironolactone is widely used as part of feminizing hormone therapy for transgender women, typically alongside estradiol. Its effect on facial hair in this population is real but more modest than many people hope. A systematic review found that estrogen-based therapy generally has a greater effect on body hair than on facial hair, and only about 28% of adult transgender women reported decreased facial hair at 12 months of treatment that included anti-androgens.16PubMed Central. Dermatologic Care of Hair in Transgender Patients: A Systematic Review of Literature Adolescents fared considerably better, with over 70% reporting decreased facial hair, likely because terminal facial hair has had less time to become fully established.
The reason for this limited response in adults comes down to a practical reality: once androgens have fully converted a facial hair follicle to produce thick, dark, terminal hair, that follicle is stubbornly resistant to reverting. Blocking further androgen stimulation with spironolactone can slow new terminal hair conversion and make existing hairs somewhat finer, but it rarely eliminates an established beard pattern. This is why laser hair removal and electrolysis remain essential parts of facial hair management for most transgender women, with spironolactone playing a supportive rather than standalone role.17Clinical and Experimental Dermatology. Effect of gender-affirming hormone therapy on hair growth: a systematic review of the literature
Why Quality of Life Does Not Always Track With Improvement
An underappreciated finding in the hirsutism literature is that quality-of-life scores do not always improve even when clinical measures of hair growth get better. One study that assessed women on combined oral contraceptive and spironolactone therapy found that while hirsutism scores improved, self-reported quality of life did not change significantly over the same period.18Gynécologie Obstétrique Fertilité & Sénologie. Contraception œstroprogestative et spironolactone dans l’hirsutisme: efficacité et impact sur la qualité de vie This disconnect probably reflects several things: the emotional burden of hirsutism runs deep and does not resolve as quickly as the physical measurement improves, the remaining hair (even if reduced) may still feel distressing, and the side effects of the medication itself can offset the psychological gains from less hair growth.
For anyone starting spironolactone with the expectation that improved scores on a clinical scale will translate directly into feeling better about themselves, this is worth knowing. The drug works on the hair, but managing the broader emotional and cosmetic impact of hirsutism often requires additional strategies, whether that means professional hair removal, counseling, or simply patience as the medication takes its full effect over many months.